2022 Annual Report of The Journal of Cardiovascular Aging

Published on: 31 Jan 2023 Viewed: 865

In 2022, The Journal of Cardiovascular Aging (JCA) has been committed to publishing valuable research results with the joint efforts of many world's influential researchers in the field of cardiovascular aging and made excellent progress and breakthroughs. We sincerely appreciate the continuous support from the Editorial Board members, authors, reviewers and readers.

Here, the Editorial Office summarizes the achievements of the journal in 2022 from the following aspects:

1. Publications

In 2022, JCA published four issues (Figure 1), including 47 articles. The proportion of each article type published is shown in Figure 2. These articles cover a wide range of research fields and have achieved 76,781 views and 20,500 downloads.

Figure 1. Covers of published issues in 2022

Figure 2. The proportion of each article type published

Among all the articles published in JCA, 40 articles funded by the National Institutes of Health (NIH) were listed in PubMed & PMC (Figure 3).

Figure 3. Articles listed in PubMed & PMC

The following statistics show the most read(Table 1), most downloaded (Table 2), most cited (Table 3), and highest Altmetric attention score articles (Figure 4) in JCA.

Table 1. Most read articlespublished in JCA
Mutant SRF and YAP synthetic modified mRNAs drive cardiomyocyte nuclear replicationSiyu Xiao, Rui Liang, Azeez B. Muili, Xuanye Cao, Stephen Navran, Robert J. Schwartz, Dinakar Iyer5909597
STEMIN and YAP5SA synthetic modified mRNAs regenerate and repair infarcted mouse heartsSiyu Xiao#, Rui Liang#, Emilio Lucero#, Bradley K. McConnell, Zhishi Chen, Jiang Chang, Stephen Navran, Robert J. Schwartz, Dinakar Iyer4977709
Epigenetic dysregulation in cardiovascular aging and diseaseAllison B. Herman, James R. Occean, Payel Sen36201099
Promoting healthy cardiovascular aging: emerging topicsZachary S. Clayton#, Daniel H. Craighead#, Sanna Darvish, McKinley Coppock, Katelyn R. Ludwig, Vienna E. Brunt, Douglas R. Seals, Matthew J. Rossman29681059
S-nitrosoglutathione reductase (GSNOR) deficiency accelerates cardiomyocyte differentiation of induced pluripotent stem cellsAlessandro G. Salerno, Amarylis C. B. A. Wanschel, Raul A. Dulce, Konstantinos E. Hatzistergos, Wayne Balkan, Joshua M. Hare2864519
#Authors contributed equally. Data accessed on January 31, 2023.

Table 2. Most downloaded articles published in JCA
Cancer treatment-induced NAD+ depletion in premature senescence and late cardiovascular complicationsPriyanka Banerjee, Elizabeth A. Olmsted-Davis, Anita Deswal, Minh TH. Nguyen, Efstratios Koutroumpakis, Nicholas L. Palaskas, Steven H. Lin, Sivareddy Kotla, Cielito Reyes-Gibby, Sai-Ching J. Yeung, Syed Wamique Yusuf, Momoko Yoshimoto, Michihiro Kobayashi, Bing Yu, Keri Schadler, Joerg Herrmann, John P. Cooke, Abhishek Jain, Eduardo Chini, Nhat-Tu Le, Jun-Ichi Abe28441157
Epigenetic dysregulation in cardiovascular aging and diseaseAllison B. Herman, James R. Occean, Payel Sen36201099
Promoting healthy cardiovascular aging: emerging topicsZachary S. Clayton#, Daniel H. Craighead#, Sanna Darvish, McKinley Coppock, Katelyn R. Ludwig, Vienna E. Brunt, Douglas R. Seals, Matthew J. Rossman29681059
Metabolic targets in cardiac aging and rejuvenationChang Liu, Xiao Zhang, Meiyu Hu, Yi Lu, Priyanka Gokulnath, Gururaja Vulugundam, Junjie Xiao1611841
Editors' Preamble to The Journal of Cardiovascular AgingAli J. Marian, Babken Asatryan, Roberto Bolli, Sirisha M. Cheedipudi, Naranjan S. Dhalla, Toren Finkel, Nikolaos G. Frangogiannis, Priyatansh Gurha, Juan Carlos Izpisua Belmonte, Joshua M. Hare, Kui Hong, Lorrie A. Kirshenbaum, Richard T. Lee, Massoud A. Leesar, Peter Libby, Rosalinda Madonna, Sherif F. Nagueh, Robert Roberts, Anthony Rosenzweig, Leila Rouhi, Junichi Sadoshima, Mark Alan Sussman, George E. Taffet, Hirofumi Tanaka, Daniele Torella, Yibin Wang, Dao Wen Wang2488790
#Authors contributed equally. Data accessed on January 31, 2023.

Table 3. Most cited articles published in JCA
(Web of Science)
Hematopoietic JAK2V617F-mediated clonal hematopoiesis: AIM2 understand mechanisms of atherogenesisSoichi Sano, Kenneth Walsh6
Epigenetic dysregulation in cardiovascular aging and diseaseAllison B. Herman, James R. Occean, Payel Sen5
Gut microbiota in sarcopenia and heart failureChia-Feng Liu, W. H. Wilson Tang3
Associations between estimated and measured carotid-femoral pulse wave velocity in older Black and White adults: the atherosclerosis risk in communities (ARIC) studyKevin Heffernan, Lee Stoner, Michelle L. Meyer, Adam Keifer, Lauren Bates, Patricia Pagan Lassalle, Erik D. Hanson, Masahiro Horiuchi, Erin D. Michos, Anna Kucharska-Newton, Kunihiro Matsushita, Timothy M. Hughes, Hirofumi Tanaka3
The WNT/β-catenin pathway regulates expression of the genes involved in cell cycle progression and mitochondrial oxidative phosphorylation in the postmitotic cardiac myocytesMelis Olcum#, Sirisha M. Cheedipudi#, Leila Rouhi, Siyang Fan, Hyun-Hwan Jeong, Zhongming Zhao, Priyatansh Gurha, Ali J. Marian2
Pharmacological suppression of the WNT signaling pathway attenuates age-dependent expression of the phenotype in a mouse model of arrhythmogenic cardiomyopathySirisha M. Cheedipudi#, Siyang Fan#, Leila Rouhi, Ali J. Marian2
Why animal model studies are lost in translationNikolaos G. Frangogiannis2
Mechanisms and implications of sex differences in cardiac agingAykhan Yusifov, Kathleen C. Woulfe, Danielle R. Bruns2
#Authors contributed equally. Data accessed on January 31, 2023.

Figure 4. Articles with the highest Altmetric attention score

JCA Editorial team is an efficiency-oriented team that has been working hard to reduce the turnaround time for manuscripts. In 2022, for peer-reviewed articles, the time from submission to first decision is 18 days, the time from submission to publication is 31 days, excluding the time that authors spend on revision. As Dr. Marian emphasized in the Editorial Board Meeting, the quality of published papers and the high efficiency of manuscript processing should be one of the strengths JCA strives for.

2. Editorial Board

In 2022, seven extraordinary scholars newly joined JCA (Table 4). The Editorial Board of JCA now has 50 experts from 12 countries, including the USA, China, the UK, Italy, Canada, Germany, Australia, Spain, Japan, Singapore, France, and Greece (Figure 5). Seventeen Editorial Board members worldwide participated in the 3rd Editorial Board Meeting of JCA on April 19, 2022 and had in-depth exchanges on key decisions related to the journal's development (Figure 6).

Table 4. New Editorial Board members
Raffaella Lombardi, MD, PhDUniversity of Naples "Federico II"
Jianyi (Jay) Zhang, MD, PhDUniversity of Alabama at Birmingham
Danielle R. Bruns, PhDUniversity of Wyoming
Jennifer GambleThe University of Sydney
Na Li, PhDBaylor College of Medicine
Phillip C. Yang, MDStanford University School of Medicine
Young-sup Yoon, MD, PhDEmory University

Figure 5. Distribution by countries/regions of Editorial Board members

Figure 6. The 3rd Editorial Board Meeting of JCA

3. Authorship

The Authors of JCA are from over 11 countries and regions (Figure 7), including the USA, China, Japan, Italy, the UK, etc. Many of the authors work in world-renowned institutes, including Harvard University, Harvard Medical School, Johns Hopkins University, Brigham Women's Hospital, the University of Texas System, Washington University School of Medicine, Mayo Clinic, Monash University, Massachusetts General Hospital, Capital Medical University, etc. And their research work is supported by major grants, including the National Institutes of Health (NIH) grants, the National Natural Science Foundation of China, the National Research Foundation of Korea, etc.

Figure 7. Distribution by countries/regions of Authorship

4. Readership

The readers of JCA are globally distributed (Figure 8), including the USA, the UK, Canada, Germany, Russia, China, Japan, Australia, India, Italy, etc.

Figure 8. Distribution by countries/regions of Readership

5. Membership

In May 2022, JCA officially became a member of the Committee on Publication Ethics (COPE). JCA consistently adheres to the COPE Code of Conduct and follows the Best Practice Guidelines for Journal Editors to ensure a rigorous peer-review process under strict ethical policies. That month, JCA reached cooperation with ResearchGate, a platform dedicated to helping scholars connect, collaborate, and share their work (Figure 9).

Figure 9. COPE logo and ResearchGate logo

6. Indexing

It is encouraging to note that JCA has been indexed in Google Scholar, Dimensions, and Lens (Figure 10).

Figure 10. Logos of Google Scholar, Dimensions, and Lens

7. Features


The JCA webinars are scheduled once a month. We invite distinguished scientists to exchange ideas and share research results and always welcome people working in related fields from all over the world to participate in the events, which not only facilitate the communication of researchers but also raise the visibility of the journal.

For the first webinar successfully held on December 1, 2022, we are delighted and honored to have Dr. Guido Kroemer, who defined the "Hallmarks of Aging" about a decade ago, as our inaugural speaker. He revisited the hallmarks in the event.

The second webinar "Inflammation in Atherosclerosis - A Translational Journey" was successfully held on January 6, 2023. It was a great honor and pleasure to have Dr. Peter Libby as the webinar Speaker to deliver an excellent report on inflammation in atherosclerosis.

Both events were huge successes (Figure 11), with over 40,000 people watching the webinars via ZOOM and other live broadcast platforms!

Figure 11. The 1st and 2nd webinars of JCA


In 2022, JCA published two podcasts from Editor-in-Chief Dr. Marian about publishing research work (Figure 12). Please stay tuned for more podcasts from more distinguished experts!

Figure 12. The podcasts of JCA

8. Conference & Collaboration

The 9th Meeting of North American Section of the International Academy of Cardiovascular Sciences (IACS) and the 41st International Society for Heart Research (ISHR) meeting were successfully held from September 6 to 9, 2022, in Winnipeg, Manitoba, Canada. JCA was presented at the meeting as an official journal of IACS and a sponsor of the scientific meetings (Figure 13).

Figure 13. The Editors of JCA attended the 9th Meeting of North American Section of the IACS and the 41st ISHR meeting

To further promote the innovative development of journals and increase the influence and visibility of JCA in related fields, in 2022, we successfully cooperated with four international conferences, which encourage academic exchanges, promote the publications, and raise the visibility of JCA (Figure 14).

Figure 14. Logos of the JCA cooperation conferences

9. Social Media

We always update on Twitter (@JCA_Journal) new articles in JCA as well as related news. In 2022, we had 588 new followers. Thanks for all the retweets and likes!

Video abstracts of published Original Research articles, webinar replays, interviews, and other video materials will be displayed on the journal's YouTube (@thejournalofcardiovascular3010).

JCA is committed to disseminating scientific research and promoting scientific innovation in the aging and cardiovascular disease. Thanks again to all the experts who have contributed to JCA in 2022. In the future, JCA will adhere to publishing more valuable and high-quality papers as well as bringing more wonderful webinars and interviews to promote the development and progress of this field.

Respectfully Submitted by the Editorial Office of JCA.

The Journal of Cardiovascular Aging


All published articles are preserved here permanently:


All published articles are preserved here permanently: